Argus Upgrades AstraZeneca To Buy, Says Discount Is Too Steep Against Pipeline Potential
August 29, 2016 at 10:39 AM EDT
AstraZeneca plc (ADR) (NYSE: AZN) shares are currently trading at a discount to S&P 500 pharma companies. Argus’ John Eade ...